Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 7 studies | 43% ± 15% | |
glutamatergic neuron | 5 studies | 27% ± 16% | |
GABAergic neuron | 4 studies | 37% ± 18% | |
interneuron | 4 studies | 55% ± 20% | |
neuron | 3 studies | 28% ± 18% | |
GABAergic amacrine cell | 3 studies | 24% ± 6% | |
oligodendrocyte precursor cell | 3 studies | 24% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 44% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2445.59 | 2641 / 2642 | 5% | 0.08 | 32 / 705 |
ovary | 47% | 131.70 | 85 / 180 | 50% | 1.33 | 213 / 430 |
thymus | 93% | 368.73 | 609 / 653 | 0% | 0.00 | 1 / 605 |
blood vessel | 82% | 258.85 | 1096 / 1335 | 0% | 0 | 0 / 0 |
uterus | 78% | 231.95 | 132 / 170 | 0% | 0.00 | 1 / 459 |
intestine | 59% | 211.93 | 568 / 966 | 1% | 0.01 | 4 / 527 |
bladder | 57% | 190.00 | 12 / 21 | 0% | 0 | 0 / 504 |
esophagus | 49% | 136.79 | 703 / 1445 | 3% | 0.13 | 5 / 183 |
prostate | 44% | 109.31 | 108 / 245 | 0% | 0 | 0 / 502 |
lung | 42% | 100.97 | 245 / 578 | 0% | 0 | 0 / 1155 |
adipose | 30% | 69.21 | 357 / 1204 | 0% | 0 | 0 / 0 |
skin | 28% | 115.68 | 514 / 1809 | 0% | 0 | 0 / 472 |
stomach | 27% | 77.11 | 98 / 359 | 1% | 0.02 | 3 / 286 |
muscle | 19% | 44.26 | 156 / 803 | 0% | 0 | 0 / 0 |
breast | 19% | 41.88 | 88 / 459 | 0% | 0 | 0 / 1118 |
heart | 15% | 32.62 | 127 / 861 | 0% | 0 | 0 / 0 |
kidney | 7% | 16.42 | 6 / 89 | 0% | 0 | 0 / 901 |
adrenal gland | 6% | 13.66 | 15 / 258 | 0% | 0 | 0 / 230 |
pancreas | 0% | 0.62 | 1 / 328 | 0% | 0 | 0 / 178 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005886 | Cellular component | plasma membrane |
Gene name | TMEFF1 |
Protein name | Tomoregulin-1 (TR-1) (H7365) (Transmembrane protein with EGF-like and one follistatin-like domain) |
Synonyms | C9orf2 |
Description | FUNCTION: May inhibit NODAL and BMP signaling during neural patterning (By similarity). May be a tumor suppressor in brain cancers. . |
Accessions | ENST00000374879.5 [Q8IYR6-1] Q8IYR6 |